tirzepatide surmount 2 once weekly for the treatment of obesity in people with type diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Lilly released results for SURMOUNT-2,
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19













:max_bytes(150000):strip_icc()/VWH-Zepbound-a91ec7a305e8407d83daa7b41039b4aa.jpg)














